financetom
PRPH
financetom
/
Healthcare
/
PRPH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
ProPhase Labs, Inc.PRPH
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States.

The company operates in two segments, Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

The company also offers contract manufacturing services, such as consumer product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services.

In addition, it is involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations.

The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Latest News >
Montage Gold Closes Second Tranche of Investment in Australia-listed African Gold
Montage Gold Closes Second Tranche of Investment in Australia-listed African Gold
Jun 13, 2025
07:43 AM EDT, 06/13/2025 (MT Newswires) -- Montage Gold ( MAUTF ) overnight Thursday said it closed the second tranche of its previously announced investment in African Gold Limited . In the second tranche of the share exchange Montage received 46.4-million African Gold ordinary shares and African Gold got 1 million Montage common shares. The company entered into a technical...
Zai Lab Reports Positive Results From Preclinical Study of ZL-1503 in Atopic Dermatitis
Zai Lab Reports Positive Results From Preclinical Study of ZL-1503 in Atopic Dermatitis
Jun 13, 2025
07:51 AM EDT, 06/13/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said Friday that new data from its preclinical study of ZL-1503 demonstrated the product candidate's potential as a treatment for moderate-to-severe atopic dermatitis, or AD. The company said results from the preclinical study in non-human primates showed that a single intravenous dose of ZL-1503 completely inhibited IL-13-mediated pSTAT6...
U.S. equity fund outflows ease on cooling inflation pressure, trade deal optimism
U.S. equity fund outflows ease on cooling inflation pressure, trade deal optimism
Jun 13, 2025
(Reuters) -U.S. equity funds witnessed the smallest weekly net disposal in four weeks in the week through June 11 as a smaller than expected rise in consumer prices in May, and a U.S. trade deal with China, eased investor worries. According to LSEG Lipper data, investors liquidated just $212 million worth of U.S. equity funds during the week, the smallest...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved